Filing Details
- Accession Number:
- 0001140361-14-010103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-28 10:15:42
- Reporting Period:
- 2014-02-26
- Filing Date:
- 2014-02-28
- Accepted Time:
- 2014-02-28 10:15:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 864683 | Cyberonics Inc | CYBX | Electromedical & Electrotherapeutic Apparatus (3845) | 760236465 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1464578 | D Bryan Olin | 100 Cyberonics Blvd Houston TX 77058 | Vp Clinical Quality Regulatory | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-26 | 4,250 | $14.72 | 67,674 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-26 | 3,082 | $24.33 | 70,756 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-26 | 3,340 | $25.71 | 74,096 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-26 | 10,672 | $68.34 | 63,424 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock | Acquisiton | 2014-02-26 | 4,250 | $0.00 | 4,250 | $14.72 |
| Common Stock | Common Stock | Acquisiton | 2014-02-26 | 3,082 | $0.00 | 3,082 | $24.33 |
| Common Stock | Common Stock | Acquisiton | 2014-02-26 | 3,340 | $0.00 | 3,340 | $25.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,418 | 2019-06-08 | No | 4 | M | Direct | |
| 27,336 | 2020-06-15 | No | 4 | M | Direct | |
| 23,996 | 2021-06-15 | No | 4 | M | Direct |
Footnotes
- Represents weighted average selling price. Securities were sold through approximately 75 separate sales on the transaction date at prices ranging from $67.70 to $69.03. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer, the full information regarding the number of shares and prices at which the transaction was effected.
- Reporting Person was granted an option to purchase 45,000 shares of common stock on June 8, 2009. The option is fully vested and expires June 8, 2019. The option was subject to certain vesting and forfeiture requirements in accordance with the terms of the applicable Stock Option Agreement.
- Reporting Person was granted an option to purchase 12,330 shares of common stock on June 15, 2010, 25% of the shares under such option to vest on each of the next four anniversaries of June 15, 2010. The option to purchase such shares is subject to forfeiture prior to vesting in accordance with the terms of the Stock Option Agreement.
- Reporting Person was granted an option to purchase 13,360 shares of common stock on June 15, 2011, 25% of the shares under such option to vest on each of the next four anniversaries of June 15, 2011. The option to purchase such shares is subject to forfeiture prior to vesting in accordance with the terms of the Stock Option Agreement.
Billionaire Hedge Funds
